NO164973C - Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.

Info

Publication number
NO164973C
NO164973C NO863344A NO863344A NO164973C NO 164973 C NO164973 C NO 164973C NO 863344 A NO863344 A NO 863344A NO 863344 A NO863344 A NO 863344A NO 164973 C NO164973 C NO 164973C
Authority
NO
Norway
Prior art keywords
tetrahalo
dodecanes
dihalo
diaza
diamino
Prior art date
Application number
NO863344A
Other languages
English (en)
Norwegian (no)
Other versions
NO164973B (no
NO863344L (no
NO863344D0 (no
Inventor
Fritz Gerhart
Pierre Mamont
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO863344D0 publication Critical patent/NO863344D0/no
Publication of NO863344L publication Critical patent/NO863344L/no
Priority to NO894557A priority Critical patent/NO165878C/no
Priority to NO900699A priority patent/NO167568C/no
Publication of NO164973B publication Critical patent/NO164973B/no
Publication of NO164973C publication Critical patent/NO164973C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/15—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO863344A 1985-08-21 1986-08-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner. NO164973C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO894557A NO165878C (no) 1985-08-21 1989-11-15 2,2-dihalo-1,4-diaminobutaner.
NO900699A NO167568C (no) 1985-08-21 1990-02-13 Gem-dihalo- eller tetrahalo-1,12-diamino-4,9-diazadodecan-derivater, og diagnostiske midler inneholdende disse.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76793485A 1985-08-21 1985-08-21

Publications (4)

Publication Number Publication Date
NO863344D0 NO863344D0 (no) 1986-08-20
NO863344L NO863344L (no) 1987-02-23
NO164973B NO164973B (no) 1990-08-27
NO164973C true NO164973C (no) 1990-12-05

Family

ID=25081013

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863344A NO164973C (no) 1985-08-21 1986-08-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.

Country Status (19)

Country Link
EP (1) EP0220409B1 (zh)
JP (2) JPH0660131B2 (zh)
KR (1) KR900006124B1 (zh)
CN (1) CN1012815B (zh)
AR (1) AR242554A1 (zh)
AT (1) ATE69801T1 (zh)
AU (1) AU585052B2 (zh)
CA (1) CA1274547C (zh)
DE (1) DE3682652D1 (zh)
DK (1) DK396786A (zh)
ES (1) ES2001247A6 (zh)
FI (1) FI84817C (zh)
GR (1) GR862148B (zh)
HU (1) HUT44754A (zh)
IL (1) IL79753A0 (zh)
NO (1) NO164973C (zh)
NZ (1) NZ217247A (zh)
PT (1) PT83232B (zh)
ZA (1) ZA866180B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695654A (en) * 1985-08-21 1987-09-22 Merrell Dow Pharmaceuticals Inc. Gem-dihalo-1,8-diamino-4-aza-octanes
JPH06181890A (ja) * 1992-10-06 1994-07-05 Terumo Corp Ｍｒｉ造影剤
KR101286158B1 (ko) * 2011-08-24 2013-07-15 씨제이제일제당 (주) 발효액에서 1,4-디아미노부탄의 분리 및 정제하는 방법
CN109456198A (zh) * 2018-11-14 2019-03-12 上海阿拉丁生化科技股份有限公司 一种2,2`-二氨基-n-甲基二乙胺的合成方法
CN116162029A (zh) * 2022-12-12 2023-05-26 苏州永健生物医药有限公司 一种精胺的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004996A (en) * 1974-12-23 1977-01-25 Merck & Co., Inc. Fluorination of organic compounds
GB2082579B (en) * 1980-08-23 1984-02-08 Merrell Toraude & Co Fluorinated diaminobutane derivatives
US4695654A (en) * 1985-08-21 1987-09-22 Merrell Dow Pharmaceuticals Inc. Gem-dihalo-1,8-diamino-4-aza-octanes

Also Published As

Publication number Publication date
FI863353A0 (fi) 1986-08-19
CN86105088A (zh) 1987-04-29
CA1274547A (en) 1990-09-25
GR862148B (en) 1986-12-23
NZ217247A (en) 1989-10-27
IL79753A0 (en) 1986-11-30
EP0220409B1 (en) 1991-11-27
DK396786D0 (da) 1986-08-20
EP0220409A2 (en) 1987-05-06
KR870002046A (ko) 1987-03-28
FI863353A (fi) 1987-02-22
JPS6245565A (ja) 1987-02-27
NO164973B (no) 1990-08-27
AU585052B2 (en) 1989-06-08
NO863344L (no) 1987-02-23
AU6155786A (en) 1987-02-26
JPH0660131B2 (ja) 1994-08-10
AR242554A1 (es) 1993-04-30
FI84817C (fi) 1992-01-27
HUT44754A (en) 1988-04-28
JPH072741A (ja) 1995-01-06
DE3682652D1 (de) 1992-01-09
PT83232B (pt) 1988-07-01
JPH0798777B2 (ja) 1995-10-25
DK396786A (da) 1987-02-22
CN1012815B (zh) 1991-06-12
EP0220409A3 (en) 1988-12-14
NO863344D0 (no) 1986-08-20
ATE69801T1 (de) 1991-12-15
ES2001247A6 (es) 1988-05-01
ZA866180B (en) 1987-04-29
PT83232A (en) 1986-09-01
CA1274547C (en) 1990-09-25
KR900006124B1 (ko) 1990-08-24
FI84817B (fi) 1991-10-15

Similar Documents

Publication Publication Date Title
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO863671D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO890155L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
NO164972C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo-1,8-diamino-4-aza-octaner.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.